- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02292953
Variation in Serum Prolactin Levels During IntraCytoplasmic Sperm Injection
Variation in Serum Prolactin Levels in Response to Ovum Pickup for Patients Undergoing ICSI & it's Effect on Pregnancy Rate
Study Overview
Detailed Description
Methodology in details:
After applying inclusion and exclusion criteria to infertile patients scheduled for start of ICSI cycle at kasr alainy assisted reproduction unit, and taking the patient's informed consent for all blood samples that will be drawn from her.
The baseline serum prolactin level is recorded and the first blood sample is scheduled to be taken in operating room just before induction of anesthesia for ovum pickup. A Second blood sample will be taken two hours after aspiration of the last follicle in recovery room post-operatively.
A third final blood sample will be taken before Embryo transfer .The blood samples will be sent immediately to central laboratory in Kasr Alainy Cairo University Hospital after being obtained on every occasion, and Serum prolactin will be analyzed by immunoassay in each time.
Descriptive data such as age, type of infertility & cause will be recorded. Also result of every serum prolactin level will be recorded as well as type of protocol used for ovulation induction, number of oocytes retrieved at ovum pick up, embryo grading and day of transfer.
Serum beta human chorionic gonadotropin (B-hCG) will be drawn from the patient 2 weeks after the date of embryo transfer to determine pregnancy and recorded.
Statistical analysis will be done for the laboratory results, All statistical calculations were performed using the computer program SPSS (Statistical Package for the Social Science; SPSS Inc.) version 15 for Microsoft Windows
.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Cairo
-
Garden City, Cairo, Egypt, 11562
- Recruiting
- 11562
-
Contact:
- Ahmed M KameL, M.D
- Phone Number: 01120022332
- Email: dr.ahmed.m.kamel@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age: adult female >20 years old.
- Complaining of infertility 1ry or 2ry & scheduled for ICSI.
Exclusion Criteria:
- Hyperprolactinemia patients.
- Severe Male factor infertility
- Frozen embryo transfer cycles
- Uterine Anomalies.
- Repeated implantation failure in ICSI.
- Any contraindications for Pregnancy as(serious uncontrolled medical diseases such as Diabetes, heart disease, hypertension), mental illnesses, ovarian tumors,cancer of any location and Acute inflammatory disease).
- On medication that is known to alter prolactin levels e.g antipsychotics, Atypical agents and risperidone
- Thyroid dysfunction.
- Medical disorders affecting serum prolactin eg acromegaly ,chronic renal failure and hypothyroidism.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Difference in Serum prolactin Levels (ng/mL) between ovum pickup & Embryo transfer
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
o Correlate serum prolactin levels (ng/mL) with Pregnancy rate.
Time Frame: 6 months
|
6 months
|
|
Correlate serum prolactin levels (ng/mL) with number & quality of embryos
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ahmed M Kamel, MD, Lecturer Of obstetrics & Gynecology
Publications and helpful links
General Publications
- Boyers SP, Lavy G, Russell JB, Polan ML, DeCherney AH. Serum prolactin response to embryo transfer during human in vitro fertilization and embryo transfer. J In Vitro Fert Embryo Transf. 1987 Oct;4(5):269-72. doi: 10.1007/BF01555202.
- Kamel A, Halim AA, Shehata M, AlFarra S, El-Faissal Y, Ramadan W, Hussein AM. Changes in serum prolactin level during intracytoplasmic sperm injection, and effect on clinical pregnancy rate: a prospective observational study. BMC Pregnancy Childbirth. 2018 May 9;18(1):141. doi: 10.1186/s12884-018-1783-4.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- A13952014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
Viable BiosciencesEnrolling by invitationInfertility (IVF Patients) | Infertility Assisted Reproductive TechnologyUnited States
Clinical Trials on Serum Prolactin levels
-
Universidad Católica de ÁvilaCompletedBreastfeeding | COVID-19 InfectionSpain
-
The First Affiliated Hospital of University of...RecruitingCirrhosis | Hepotacellular CarcinomaChina
-
Diskapi Yildirim Beyazit Education and Research...Completed
-
Gaziosmanpasa Research and Education HospitalCompleted
-
Jordan University HospitalCompletedCOVID-19 | COVID-19 Respiratory InfectionJordan
-
Ankara City Hospital BilkentCompletedInsulin Resistance | Polycystic Ovary Syndrome (PCOS) | Body Mass Index (BMI) | BetatrophinTurkey (Türkiye)
-
Hatice AkkayaCompletedPre-Eclampsia | Oxidative Stress | Early Onset Preeclampsia | Immunologic Diseases in PregnancyTurkey
-
Goztepe Prof Dr Suleyman Yalcın City HospitalCompleted
-
Osijek University HospitalJosip Juraj Strossmayer University of OsijekCompletedMuscle Weakness | Respiratory Insufficiency | Intensive Care UnitCroatia
-
Saglik Bilimleri UniversitesiCompletedSleeve Gastrectomy | Adipokines | Obesity & OverweightTurkey (Türkiye)